Literature DB >> 18166999

Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy.

Wolfgang Dörr1, Jana Jaal, Daniel Zips.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18166999     DOI： 10.1007/s00066-007-2006-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.

Authors:  Georgina Fröhlich; Péter Agoston; József Lövey; András Somogyi; János Fodor; Csaba Polgár; Tibor Major
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

2.  Radiation protection of persons living close to patients with radioactive implants.

Authors:  Theodor W Kaulich; Michael Bamberg
Journal:  Strahlenther Onkol       Date:  2010-01-28       Impact factor: 3.621

3.  A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma : a report on acute toxicity.

Authors:  Darius Norkus; Albert Miller; Juozas Kurtinaitis; Uwe Haverkamp; Sergey Popov; Franz-Josef Prott; Konstantinas Povilas Valuckas
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

4.  Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer.

Authors:  Pirus Ghadjar; Nicole Gwerder; Axel Madlung; Frank Behrensmeier; George N Thalmann; Roberto Mini; Daniel M Aebersold
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

5.  Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use.

Authors:  Raffaella Cambria; Barbara A Jereczek-Fossa; Federica Cattani; Cristina Garibaldi; Dario Zerini; Cristiana Fodor; Flavia Serafini; Guido Pedroli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

6.  The impact of prostate volume changes during external-beam irradiation in consequence of HDR brachytherapy in prostate cancer treatment.

Authors:  Markus Karl Alfred Herrmann; Tammo Gsänger; Arne Strauss; Tereza Kertesz; Hendrik A Wolff; Hans Christiansen; Hilke Vorwerk; Clemens Friedrich Hess; Andrea Hille
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.